Global New Drug Modeling Solution Market Growth (Status and Outlook) 2026-2032
The global New Drug Modeling Solution market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
United States market for New Drug Modeling Solution is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for New Drug Modeling Solution is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for New Drug Modeling Solution is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key New Drug Modeling Solution players cover JSR Corporation(Crown Bioscience), Chemical Computing Group ULC, Nimbus Therapeutics, schrodinger, Inc, Genedata AG, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the ?New Drug Modeling Solution Industry Forecast? looks at past sales and reviews total world New Drug Modeling Solution sales in 2025, providing a comprehensive analysis by region and market sector of projected New Drug Modeling Solution sales for 2026 through 2032. With New Drug Modeling Solution sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world New Drug Modeling Solution industry.
This Insight Report provides a comprehensive analysis of the global New Drug Modeling Solution landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on New Drug Modeling Solution portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global New Drug Modeling Solution market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for New Drug Modeling Solution and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global New Drug Modeling Solution.
This report presents a comprehensive overview, market shares, and growth opportunities of New Drug Modeling Solution market by product type, application, key players and key regions and countries.
Segmentation by Type:
United States market for New Drug Modeling Solution is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for New Drug Modeling Solution is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for New Drug Modeling Solution is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key New Drug Modeling Solution players cover JSR Corporation(Crown Bioscience), Chemical Computing Group ULC, Nimbus Therapeutics, schrodinger, Inc, Genedata AG, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the ?New Drug Modeling Solution Industry Forecast? looks at past sales and reviews total world New Drug Modeling Solution sales in 2025, providing a comprehensive analysis by region and market sector of projected New Drug Modeling Solution sales for 2026 through 2032. With New Drug Modeling Solution sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world New Drug Modeling Solution industry.
This Insight Report provides a comprehensive analysis of the global New Drug Modeling Solution landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on New Drug Modeling Solution portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global New Drug Modeling Solution market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for New Drug Modeling Solution and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global New Drug Modeling Solution.
This report presents a comprehensive overview, market shares, and growth opportunities of New Drug Modeling Solution market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Database
- Software
- Others
- Drug Discovery and Development
- Computational Physiological Medicine
- Disease Modeling
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- JSR Corporation(Crown Bioscience)
- Chemical Computing Group ULC
- Nimbus Therapeutics
- schrodinger, Inc
- Genedata AG
- Biognos AB
- Compugen Ltd
- Dassault Systemes
- Acellera
- lnstem(Leadscope)
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global New Drug Modeling Solution Market Size (2021-2032)
2.1.2 New Drug Modeling Solution Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for New Drug Modeling Solution by Country/Region (2021, 2025 & 2032)
2.2 New Drug Modeling Solution Segment by Type
2.2.1 Database
2.2.2 Software
2.2.3 Others
2.2.4 New Drug Modeling Solution Market Size by Type
2.2.4.1 New Drug Modeling Solution Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.4.2 Global New Drug Modeling Solution Market Size Market Share by Type (2021-2026)
2.3 New Drug Modeling Solution Segment by Application
2.3.1 Drug Discovery and Development
2.3.2 Computational Physiological Medicine
2.3.3 Disease Modeling
2.3.4 Others
2.3.5 New Drug Modeling Solution Market Size by Application
2.3.5.1 New Drug Modeling Solution Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.5.2 Global New Drug Modeling Solution Market Size Market Share by Application (2021-2026)
3 NEW DRUG MODELING SOLUTION MARKET SIZE BY PLAYER
3.1 New Drug Modeling Solution Market Size Market Share by Player
3.1.1 Global New Drug Modeling Solution Revenue by Player (2021-2026)
3.1.2 Global New Drug Modeling Solution Revenue Market Share by Player (2021-2026)
3.2 Global New Drug Modeling Solution Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NEW DRUG MODELING SOLUTION BY REGION
4.1 New Drug Modeling Solution Market Size by Region (2021-2026)
4.2 Global New Drug Modeling Solution Annual Revenue by Country/Region (2021-2026)
4.3 Americas New Drug Modeling Solution Market Size Growth (2021-2026)
4.4 APAC New Drug Modeling Solution Market Size Growth (2021-2026)
4.5 Europe New Drug Modeling Solution Market Size Growth (2021-2026)
4.6 Middle East & Africa New Drug Modeling Solution Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas New Drug Modeling Solution Market Size by Country (2021-2026)
5.2 Americas New Drug Modeling Solution Market Size by Type (2021-2026)
5.3 Americas New Drug Modeling Solution Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC New Drug Modeling Solution Market Size by Region (2021-2026)
6.2 APAC New Drug Modeling Solution Market Size by Type (2021-2026)
6.3 APAC New Drug Modeling Solution Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe New Drug Modeling Solution Market Size by Country (2021-2026)
7.2 Europe New Drug Modeling Solution Market Size by Type (2021-2026)
7.3 Europe New Drug Modeling Solution Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa New Drug Modeling Solution by Region (2021-2026)
8.2 Middle East & Africa New Drug Modeling Solution Market Size by Type (2021-2026)
8.3 Middle East & Africa New Drug Modeling Solution Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NEW DRUG MODELING SOLUTION MARKET FORECAST
10.1 Global New Drug Modeling Solution Forecast by Region (2027-2032)
10.1.1 Global New Drug Modeling Solution Forecast by Region (2027-2032)
10.1.2 Americas New Drug Modeling Solution Forecast
10.1.3 APAC New Drug Modeling Solution Forecast
10.1.4 Europe New Drug Modeling Solution Forecast
10.1.5 Middle East & Africa New Drug Modeling Solution Forecast
10.2 Americas New Drug Modeling Solution Forecast by Country (2027-2032)
10.2.1 United States Market New Drug Modeling Solution Forecast
10.2.2 Canada Market New Drug Modeling Solution Forecast
10.2.3 Mexico Market New Drug Modeling Solution Forecast
10.2.4 Brazil Market New Drug Modeling Solution Forecast
10.3 APAC New Drug Modeling Solution Forecast by Region (2027-2032)
10.3.1 China New Drug Modeling Solution Market Forecast
10.3.2 Japan Market New Drug Modeling Solution Forecast
10.3.3 Korea Market New Drug Modeling Solution Forecast
10.3.4 Southeast Asia Market New Drug Modeling Solution Forecast
10.3.5 India Market New Drug Modeling Solution Forecast
10.3.6 Australia Market New Drug Modeling Solution Forecast
10.4 Europe New Drug Modeling Solution Forecast by Country (2027-2032)
10.4.1 Germany Market New Drug Modeling Solution Forecast
10.4.2 France Market New Drug Modeling Solution Forecast
10.4.3 UK Market New Drug Modeling Solution Forecast
10.4.4 Italy Market New Drug Modeling Solution Forecast
10.4.5 Russia Market New Drug Modeling Solution Forecast
10.5 Middle East & Africa New Drug Modeling Solution Forecast by Region (2027-2032)
10.5.1 Egypt Market New Drug Modeling Solution Forecast
10.5.2 South Africa Market New Drug Modeling Solution Forecast
10.5.3 Israel Market New Drug Modeling Solution Forecast
10.5.4 Turkey Market New Drug Modeling Solution Forecast
10.6 Global New Drug Modeling Solution Forecast by Type (2027-2032)
10.7 Global New Drug Modeling Solution Forecast by Application (2027-2032)
10.7.1 GCC Countries Market New Drug Modeling Solution Forecast
11 KEY PLAYERS ANALYSIS
11.1 JSR Corporation(Crown Bioscience)
11.1.1 JSR Corporation(Crown Bioscience) Company Information
11.1.2 JSR Corporation(Crown Bioscience) New Drug Modeling Solution Product Offered
11.1.3 JSR Corporation(Crown Bioscience) New Drug Modeling Solution Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 JSR Corporation(Crown Bioscience) Main Business Overview
11.1.5 JSR Corporation(Crown Bioscience) Latest Developments
11.2 Chemical Computing Group ULC
11.2.1 Chemical Computing Group ULC Company Information
11.2.2 Chemical Computing Group ULC New Drug Modeling Solution Product Offered
11.2.3 Chemical Computing Group ULC New Drug Modeling Solution Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Chemical Computing Group ULC Main Business Overview
11.2.5 Chemical Computing Group ULC Latest Developments
11.3 Nimbus Therapeutics
11.3.1 Nimbus Therapeutics Company Information
11.3.2 Nimbus Therapeutics New Drug Modeling Solution Product Offered
11.3.3 Nimbus Therapeutics New Drug Modeling Solution Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Nimbus Therapeutics Main Business Overview
11.3.5 Nimbus Therapeutics Latest Developments
11.4 schrodinger, Inc
11.4.1 schrodinger, Inc Company Information
11.4.2 schrodinger, Inc New Drug Modeling Solution Product Offered
11.4.3 schrodinger, Inc New Drug Modeling Solution Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 schrodinger, Inc Main Business Overview
11.4.5 schrodinger, Inc Latest Developments
11.5 Genedata AG
11.5.1 Genedata AG Company Information
11.5.2 Genedata AG New Drug Modeling Solution Product Offered
11.5.3 Genedata AG New Drug Modeling Solution Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Genedata AG Main Business Overview
11.5.5 Genedata AG Latest Developments
11.6 Biognos AB
11.6.1 Biognos AB Company Information
11.6.2 Biognos AB New Drug Modeling Solution Product Offered
11.6.3 Biognos AB New Drug Modeling Solution Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Biognos AB Main Business Overview
11.6.5 Biognos AB Latest Developments
11.7 Compugen Ltd
11.7.1 Compugen Ltd Company Information
11.7.2 Compugen Ltd New Drug Modeling Solution Product Offered
11.7.3 Compugen Ltd New Drug Modeling Solution Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Compugen Ltd Main Business Overview
11.7.5 Compugen Ltd Latest Developments
11.8 Dassault Systemes
11.8.1 Dassault Systemes Company Information
11.8.2 Dassault Systemes New Drug Modeling Solution Product Offered
11.8.3 Dassault Systemes New Drug Modeling Solution Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Dassault Systemes Main Business Overview
11.8.5 Dassault Systemes Latest Developments
11.9 Acellera
11.9.1 Acellera Company Information
11.9.2 Acellera New Drug Modeling Solution Product Offered
11.9.3 Acellera New Drug Modeling Solution Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Acellera Main Business Overview
11.9.5 Acellera Latest Developments
11.10 lnstem(Leadscope)
11.10.1 lnstem(Leadscope) Company Information
11.10.2 lnstem(Leadscope) New Drug Modeling Solution Product Offered
11.10.3 lnstem(Leadscope) New Drug Modeling Solution Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 lnstem(Leadscope) Main Business Overview
11.10.5 lnstem(Leadscope) Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global New Drug Modeling Solution Market Size (2021-2032)
2.1.2 New Drug Modeling Solution Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for New Drug Modeling Solution by Country/Region (2021, 2025 & 2032)
2.2 New Drug Modeling Solution Segment by Type
2.2.1 Database
2.2.2 Software
2.2.3 Others
2.2.4 New Drug Modeling Solution Market Size by Type
2.2.4.1 New Drug Modeling Solution Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.4.2 Global New Drug Modeling Solution Market Size Market Share by Type (2021-2026)
2.3 New Drug Modeling Solution Segment by Application
2.3.1 Drug Discovery and Development
2.3.2 Computational Physiological Medicine
2.3.3 Disease Modeling
2.3.4 Others
2.3.5 New Drug Modeling Solution Market Size by Application
2.3.5.1 New Drug Modeling Solution Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.5.2 Global New Drug Modeling Solution Market Size Market Share by Application (2021-2026)
3 NEW DRUG MODELING SOLUTION MARKET SIZE BY PLAYER
3.1 New Drug Modeling Solution Market Size Market Share by Player
3.1.1 Global New Drug Modeling Solution Revenue by Player (2021-2026)
3.1.2 Global New Drug Modeling Solution Revenue Market Share by Player (2021-2026)
3.2 Global New Drug Modeling Solution Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NEW DRUG MODELING SOLUTION BY REGION
4.1 New Drug Modeling Solution Market Size by Region (2021-2026)
4.2 Global New Drug Modeling Solution Annual Revenue by Country/Region (2021-2026)
4.3 Americas New Drug Modeling Solution Market Size Growth (2021-2026)
4.4 APAC New Drug Modeling Solution Market Size Growth (2021-2026)
4.5 Europe New Drug Modeling Solution Market Size Growth (2021-2026)
4.6 Middle East & Africa New Drug Modeling Solution Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas New Drug Modeling Solution Market Size by Country (2021-2026)
5.2 Americas New Drug Modeling Solution Market Size by Type (2021-2026)
5.3 Americas New Drug Modeling Solution Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC New Drug Modeling Solution Market Size by Region (2021-2026)
6.2 APAC New Drug Modeling Solution Market Size by Type (2021-2026)
6.3 APAC New Drug Modeling Solution Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe New Drug Modeling Solution Market Size by Country (2021-2026)
7.2 Europe New Drug Modeling Solution Market Size by Type (2021-2026)
7.3 Europe New Drug Modeling Solution Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa New Drug Modeling Solution by Region (2021-2026)
8.2 Middle East & Africa New Drug Modeling Solution Market Size by Type (2021-2026)
8.3 Middle East & Africa New Drug Modeling Solution Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NEW DRUG MODELING SOLUTION MARKET FORECAST
10.1 Global New Drug Modeling Solution Forecast by Region (2027-2032)
10.1.1 Global New Drug Modeling Solution Forecast by Region (2027-2032)
10.1.2 Americas New Drug Modeling Solution Forecast
10.1.3 APAC New Drug Modeling Solution Forecast
10.1.4 Europe New Drug Modeling Solution Forecast
10.1.5 Middle East & Africa New Drug Modeling Solution Forecast
10.2 Americas New Drug Modeling Solution Forecast by Country (2027-2032)
10.2.1 United States Market New Drug Modeling Solution Forecast
10.2.2 Canada Market New Drug Modeling Solution Forecast
10.2.3 Mexico Market New Drug Modeling Solution Forecast
10.2.4 Brazil Market New Drug Modeling Solution Forecast
10.3 APAC New Drug Modeling Solution Forecast by Region (2027-2032)
10.3.1 China New Drug Modeling Solution Market Forecast
10.3.2 Japan Market New Drug Modeling Solution Forecast
10.3.3 Korea Market New Drug Modeling Solution Forecast
10.3.4 Southeast Asia Market New Drug Modeling Solution Forecast
10.3.5 India Market New Drug Modeling Solution Forecast
10.3.6 Australia Market New Drug Modeling Solution Forecast
10.4 Europe New Drug Modeling Solution Forecast by Country (2027-2032)
10.4.1 Germany Market New Drug Modeling Solution Forecast
10.4.2 France Market New Drug Modeling Solution Forecast
10.4.3 UK Market New Drug Modeling Solution Forecast
10.4.4 Italy Market New Drug Modeling Solution Forecast
10.4.5 Russia Market New Drug Modeling Solution Forecast
10.5 Middle East & Africa New Drug Modeling Solution Forecast by Region (2027-2032)
10.5.1 Egypt Market New Drug Modeling Solution Forecast
10.5.2 South Africa Market New Drug Modeling Solution Forecast
10.5.3 Israel Market New Drug Modeling Solution Forecast
10.5.4 Turkey Market New Drug Modeling Solution Forecast
10.6 Global New Drug Modeling Solution Forecast by Type (2027-2032)
10.7 Global New Drug Modeling Solution Forecast by Application (2027-2032)
10.7.1 GCC Countries Market New Drug Modeling Solution Forecast
11 KEY PLAYERS ANALYSIS
11.1 JSR Corporation(Crown Bioscience)
11.1.1 JSR Corporation(Crown Bioscience) Company Information
11.1.2 JSR Corporation(Crown Bioscience) New Drug Modeling Solution Product Offered
11.1.3 JSR Corporation(Crown Bioscience) New Drug Modeling Solution Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 JSR Corporation(Crown Bioscience) Main Business Overview
11.1.5 JSR Corporation(Crown Bioscience) Latest Developments
11.2 Chemical Computing Group ULC
11.2.1 Chemical Computing Group ULC Company Information
11.2.2 Chemical Computing Group ULC New Drug Modeling Solution Product Offered
11.2.3 Chemical Computing Group ULC New Drug Modeling Solution Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Chemical Computing Group ULC Main Business Overview
11.2.5 Chemical Computing Group ULC Latest Developments
11.3 Nimbus Therapeutics
11.3.1 Nimbus Therapeutics Company Information
11.3.2 Nimbus Therapeutics New Drug Modeling Solution Product Offered
11.3.3 Nimbus Therapeutics New Drug Modeling Solution Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Nimbus Therapeutics Main Business Overview
11.3.5 Nimbus Therapeutics Latest Developments
11.4 schrodinger, Inc
11.4.1 schrodinger, Inc Company Information
11.4.2 schrodinger, Inc New Drug Modeling Solution Product Offered
11.4.3 schrodinger, Inc New Drug Modeling Solution Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 schrodinger, Inc Main Business Overview
11.4.5 schrodinger, Inc Latest Developments
11.5 Genedata AG
11.5.1 Genedata AG Company Information
11.5.2 Genedata AG New Drug Modeling Solution Product Offered
11.5.3 Genedata AG New Drug Modeling Solution Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Genedata AG Main Business Overview
11.5.5 Genedata AG Latest Developments
11.6 Biognos AB
11.6.1 Biognos AB Company Information
11.6.2 Biognos AB New Drug Modeling Solution Product Offered
11.6.3 Biognos AB New Drug Modeling Solution Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Biognos AB Main Business Overview
11.6.5 Biognos AB Latest Developments
11.7 Compugen Ltd
11.7.1 Compugen Ltd Company Information
11.7.2 Compugen Ltd New Drug Modeling Solution Product Offered
11.7.3 Compugen Ltd New Drug Modeling Solution Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Compugen Ltd Main Business Overview
11.7.5 Compugen Ltd Latest Developments
11.8 Dassault Systemes
11.8.1 Dassault Systemes Company Information
11.8.2 Dassault Systemes New Drug Modeling Solution Product Offered
11.8.3 Dassault Systemes New Drug Modeling Solution Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Dassault Systemes Main Business Overview
11.8.5 Dassault Systemes Latest Developments
11.9 Acellera
11.9.1 Acellera Company Information
11.9.2 Acellera New Drug Modeling Solution Product Offered
11.9.3 Acellera New Drug Modeling Solution Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Acellera Main Business Overview
11.9.5 Acellera Latest Developments
11.10 lnstem(Leadscope)
11.10.1 lnstem(Leadscope) Company Information
11.10.2 lnstem(Leadscope) New Drug Modeling Solution Product Offered
11.10.3 lnstem(Leadscope) New Drug Modeling Solution Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 lnstem(Leadscope) Main Business Overview
11.10.5 lnstem(Leadscope) Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. New Drug Modeling Solution Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. New Drug Modeling Solution Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Database
Table 4. Major Players of Software
Table 5. Major Players of Others
Table 6. New Drug Modeling Solution Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global New Drug Modeling Solution Market Size by Type (2021-2026) & ($ millions)
Table 8. Global New Drug Modeling Solution Market Size Market Share by Type (2021-2026)
Table 9. New Drug Modeling Solution Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 10. Global New Drug Modeling Solution Market Size by Application (2021-2026) & ($ millions)
Table 11. Global New Drug Modeling Solution Market Size Market Share by Application (2021-2026)
Table 12. Global New Drug Modeling Solution Revenue by Player (2021-2026) & ($ millions)
Table 13. Global New Drug Modeling Solution Revenue Market Share by Player (2021-2026)
Table 14. New Drug Modeling Solution Key Players Head office and Products Offered
Table 15. New Drug Modeling Solution Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global New Drug Modeling Solution Market Size by Region (2021-2026) & ($ millions)
Table 19. Global New Drug Modeling Solution Market Size Market Share by Region (2021-2026)
Table 20. Global New Drug Modeling Solution Revenue by Country/Region (2021-2026) & ($ millions)
Table 21. Global New Drug Modeling Solution Revenue Market Share by Country/Region (2021-2026)
Table 22. Americas New Drug Modeling Solution Market Size by Country (2021-2026) & ($ millions)
Table 23. Americas New Drug Modeling Solution Market Size Market Share by Country (2021-2026)
Table 24. Americas New Drug Modeling Solution Market Size by Type (2021-2026) & ($ millions)
Table 25. Americas New Drug Modeling Solution Market Size Market Share by Type (2021-2026)
Table 26. Americas New Drug Modeling Solution Market Size by Application (2021-2026) & ($ millions)
Table 27. Americas New Drug Modeling Solution Market Size Market Share by Application (2021-2026)
Table 28. APAC New Drug Modeling Solution Market Size by Region (2021-2026) & ($ millions)
Table 29. APAC New Drug Modeling Solution Market Size Market Share by Region (2021-2026)
Table 30. APAC New Drug Modeling Solution Market Size by Type (2021-2026) & ($ millions)
Table 31. APAC New Drug Modeling Solution Market Size by Application (2021-2026) & ($ millions)
Table 32. Europe New Drug Modeling Solution Market Size by Country (2021-2026) & ($ millions)
Table 33. Europe New Drug Modeling Solution Market Size Market Share by Country (2021-2026)
Table 34. Europe New Drug Modeling Solution Market Size by Type (2021-2026) & ($ millions)
Table 35. Europe New Drug Modeling Solution Market Size by Application (2021-2026) & ($ millions)
Table 36. Middle East & Africa New Drug Modeling Solution Market Size by Region (2021-2026) & ($ millions)
Table 37. Middle East & Africa New Drug Modeling Solution Market Size by Type (2021-2026) & ($ millions)
Table 38. Middle East & Africa New Drug Modeling Solution Market Size by Application (2021-2026) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of New Drug Modeling Solution
Table 40. Key Market Challenges & Risks of New Drug Modeling Solution
Table 41. Key Industry Trends of New Drug Modeling Solution
Table 42. Global New Drug Modeling Solution Market Size Forecast by Region (2027-2032) & ($ millions)
Table 43. Global New Drug Modeling Solution Market Size Market Share Forecast by Region (2027-2032)
Table 44. Global New Drug Modeling Solution Market Size Forecast by Type (2027-2032) & ($ millions)
Table 45. Global New Drug Modeling Solution Market Size Forecast by Application (2027-2032) & ($ millions)
Table 46. JSR Corporation(Crown Bioscience) Details, Company Type, New Drug Modeling Solution Area Served and Its Competitors
Table 47. JSR Corporation(Crown Bioscience) New Drug Modeling Solution Product Offered
Table 48. JSR Corporation(Crown Bioscience) New Drug Modeling Solution Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 49. JSR Corporation(Crown Bioscience) Main Business
Table 50. JSR Corporation(Crown Bioscience) Latest Developments
Table 51. Chemical Computing Group ULC Details, Company Type, New Drug Modeling Solution Area Served and Its Competitors
Table 52. Chemical Computing Group ULC New Drug Modeling Solution Product Offered
Table 53. Chemical Computing Group ULC New Drug Modeling Solution Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 54. Chemical Computing Group ULC Main Business
Table 55. Chemical Computing Group ULC Latest Developments
Table 56. Nimbus Therapeutics Details, Company Type, New Drug Modeling Solution Area Served and Its Competitors
Table 57. Nimbus Therapeutics New Drug Modeling Solution Product Offered
Table 58. Nimbus Therapeutics New Drug Modeling Solution Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 59. Nimbus Therapeutics Main Business
Table 60. Nimbus Therapeutics Latest Developments
Table 61. schrodinger, Inc Details, Company Type, New Drug Modeling Solution Area Served and Its Competitors
Table 62. schrodinger, Inc New Drug Modeling Solution Product Offered
Table 63. schrodinger, Inc New Drug Modeling Solution Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. schrodinger, Inc Main Business
Table 65. schrodinger, Inc Latest Developments
Table 66. Genedata AG Details, Company Type, New Drug Modeling Solution Area Served and Its Competitors
Table 67. Genedata AG New Drug Modeling Solution Product Offered
Table 68. Genedata AG New Drug Modeling Solution Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. Genedata AG Main Business
Table 70. Genedata AG Latest Developments
Table 71. Biognos AB Details, Company Type, New Drug Modeling Solution Area Served and Its Competitors
Table 72. Biognos AB New Drug Modeling Solution Product Offered
Table 73. Biognos AB New Drug Modeling Solution Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. Biognos AB Main Business
Table 75. Biognos AB Latest Developments
Table 76. Compugen Ltd Details, Company Type, New Drug Modeling Solution Area Served and Its Competitors
Table 77. Compugen Ltd New Drug Modeling Solution Product Offered
Table 78. Compugen Ltd New Drug Modeling Solution Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. Compugen Ltd Main Business
Table 80. Compugen Ltd Latest Developments
Table 81. Dassault Systemes Details, Company Type, New Drug Modeling Solution Area Served and Its Competitors
Table 82. Dassault Systemes New Drug Modeling Solution Product Offered
Table 83. Dassault Systemes New Drug Modeling Solution Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. Dassault Systemes Main Business
Table 85. Dassault Systemes Latest Developments
Table 86. Acellera Details, Company Type, New Drug Modeling Solution Area Served and Its Competitors
Table 87. Acellera New Drug Modeling Solution Product Offered
Table 88. Acellera New Drug Modeling Solution Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 89. Acellera Main Business
Table 90. Acellera Latest Developments
Table 91. lnstem(Leadscope) Details, Company Type, New Drug Modeling Solution Area Served and Its Competitors
Table 92. lnstem(Leadscope) New Drug Modeling Solution Product Offered
Table 93. lnstem(Leadscope) New Drug Modeling Solution Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 94. lnstem(Leadscope) Main Business
Table 95. lnstem(Leadscope) Latest Developments
Table 1. New Drug Modeling Solution Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. New Drug Modeling Solution Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Database
Table 4. Major Players of Software
Table 5. Major Players of Others
Table 6. New Drug Modeling Solution Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global New Drug Modeling Solution Market Size by Type (2021-2026) & ($ millions)
Table 8. Global New Drug Modeling Solution Market Size Market Share by Type (2021-2026)
Table 9. New Drug Modeling Solution Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 10. Global New Drug Modeling Solution Market Size by Application (2021-2026) & ($ millions)
Table 11. Global New Drug Modeling Solution Market Size Market Share by Application (2021-2026)
Table 12. Global New Drug Modeling Solution Revenue by Player (2021-2026) & ($ millions)
Table 13. Global New Drug Modeling Solution Revenue Market Share by Player (2021-2026)
Table 14. New Drug Modeling Solution Key Players Head office and Products Offered
Table 15. New Drug Modeling Solution Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global New Drug Modeling Solution Market Size by Region (2021-2026) & ($ millions)
Table 19. Global New Drug Modeling Solution Market Size Market Share by Region (2021-2026)
Table 20. Global New Drug Modeling Solution Revenue by Country/Region (2021-2026) & ($ millions)
Table 21. Global New Drug Modeling Solution Revenue Market Share by Country/Region (2021-2026)
Table 22. Americas New Drug Modeling Solution Market Size by Country (2021-2026) & ($ millions)
Table 23. Americas New Drug Modeling Solution Market Size Market Share by Country (2021-2026)
Table 24. Americas New Drug Modeling Solution Market Size by Type (2021-2026) & ($ millions)
Table 25. Americas New Drug Modeling Solution Market Size Market Share by Type (2021-2026)
Table 26. Americas New Drug Modeling Solution Market Size by Application (2021-2026) & ($ millions)
Table 27. Americas New Drug Modeling Solution Market Size Market Share by Application (2021-2026)
Table 28. APAC New Drug Modeling Solution Market Size by Region (2021-2026) & ($ millions)
Table 29. APAC New Drug Modeling Solution Market Size Market Share by Region (2021-2026)
Table 30. APAC New Drug Modeling Solution Market Size by Type (2021-2026) & ($ millions)
Table 31. APAC New Drug Modeling Solution Market Size by Application (2021-2026) & ($ millions)
Table 32. Europe New Drug Modeling Solution Market Size by Country (2021-2026) & ($ millions)
Table 33. Europe New Drug Modeling Solution Market Size Market Share by Country (2021-2026)
Table 34. Europe New Drug Modeling Solution Market Size by Type (2021-2026) & ($ millions)
Table 35. Europe New Drug Modeling Solution Market Size by Application (2021-2026) & ($ millions)
Table 36. Middle East & Africa New Drug Modeling Solution Market Size by Region (2021-2026) & ($ millions)
Table 37. Middle East & Africa New Drug Modeling Solution Market Size by Type (2021-2026) & ($ millions)
Table 38. Middle East & Africa New Drug Modeling Solution Market Size by Application (2021-2026) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of New Drug Modeling Solution
Table 40. Key Market Challenges & Risks of New Drug Modeling Solution
Table 41. Key Industry Trends of New Drug Modeling Solution
Table 42. Global New Drug Modeling Solution Market Size Forecast by Region (2027-2032) & ($ millions)
Table 43. Global New Drug Modeling Solution Market Size Market Share Forecast by Region (2027-2032)
Table 44. Global New Drug Modeling Solution Market Size Forecast by Type (2027-2032) & ($ millions)
Table 45. Global New Drug Modeling Solution Market Size Forecast by Application (2027-2032) & ($ millions)
Table 46. JSR Corporation(Crown Bioscience) Details, Company Type, New Drug Modeling Solution Area Served and Its Competitors
Table 47. JSR Corporation(Crown Bioscience) New Drug Modeling Solution Product Offered
Table 48. JSR Corporation(Crown Bioscience) New Drug Modeling Solution Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 49. JSR Corporation(Crown Bioscience) Main Business
Table 50. JSR Corporation(Crown Bioscience) Latest Developments
Table 51. Chemical Computing Group ULC Details, Company Type, New Drug Modeling Solution Area Served and Its Competitors
Table 52. Chemical Computing Group ULC New Drug Modeling Solution Product Offered
Table 53. Chemical Computing Group ULC New Drug Modeling Solution Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 54. Chemical Computing Group ULC Main Business
Table 55. Chemical Computing Group ULC Latest Developments
Table 56. Nimbus Therapeutics Details, Company Type, New Drug Modeling Solution Area Served and Its Competitors
Table 57. Nimbus Therapeutics New Drug Modeling Solution Product Offered
Table 58. Nimbus Therapeutics New Drug Modeling Solution Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 59. Nimbus Therapeutics Main Business
Table 60. Nimbus Therapeutics Latest Developments
Table 61. schrodinger, Inc Details, Company Type, New Drug Modeling Solution Area Served and Its Competitors
Table 62. schrodinger, Inc New Drug Modeling Solution Product Offered
Table 63. schrodinger, Inc New Drug Modeling Solution Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. schrodinger, Inc Main Business
Table 65. schrodinger, Inc Latest Developments
Table 66. Genedata AG Details, Company Type, New Drug Modeling Solution Area Served and Its Competitors
Table 67. Genedata AG New Drug Modeling Solution Product Offered
Table 68. Genedata AG New Drug Modeling Solution Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. Genedata AG Main Business
Table 70. Genedata AG Latest Developments
Table 71. Biognos AB Details, Company Type, New Drug Modeling Solution Area Served and Its Competitors
Table 72. Biognos AB New Drug Modeling Solution Product Offered
Table 73. Biognos AB New Drug Modeling Solution Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. Biognos AB Main Business
Table 75. Biognos AB Latest Developments
Table 76. Compugen Ltd Details, Company Type, New Drug Modeling Solution Area Served and Its Competitors
Table 77. Compugen Ltd New Drug Modeling Solution Product Offered
Table 78. Compugen Ltd New Drug Modeling Solution Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. Compugen Ltd Main Business
Table 80. Compugen Ltd Latest Developments
Table 81. Dassault Systemes Details, Company Type, New Drug Modeling Solution Area Served and Its Competitors
Table 82. Dassault Systemes New Drug Modeling Solution Product Offered
Table 83. Dassault Systemes New Drug Modeling Solution Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. Dassault Systemes Main Business
Table 85. Dassault Systemes Latest Developments
Table 86. Acellera Details, Company Type, New Drug Modeling Solution Area Served and Its Competitors
Table 87. Acellera New Drug Modeling Solution Product Offered
Table 88. Acellera New Drug Modeling Solution Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 89. Acellera Main Business
Table 90. Acellera Latest Developments
Table 91. lnstem(Leadscope) Details, Company Type, New Drug Modeling Solution Area Served and Its Competitors
Table 92. lnstem(Leadscope) New Drug Modeling Solution Product Offered
Table 93. lnstem(Leadscope) New Drug Modeling Solution Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 94. lnstem(Leadscope) Main Business
Table 95. lnstem(Leadscope) Latest Developments
LIST OF FIGURES
Figure 1. New Drug Modeling Solution Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global New Drug Modeling Solution Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. New Drug Modeling Solution Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. New Drug Modeling Solution Sales Market Share by Country/Region (2025)
Figure 8. New Drug Modeling Solution Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global New Drug Modeling Solution Market Size Market Share by Type in 2025
Figure 10. New Drug Modeling Solution in Drug Discovery and Development
Figure 11. Global New Drug Modeling Solution Market: Drug Discovery and Development (2021-2026) & ($ millions)
Figure 12. New Drug Modeling Solution in Computational Physiological Medicine
Figure 13. Global New Drug Modeling Solution Market: Computational Physiological Medicine (2021-2026) & ($ millions)
Figure 14. New Drug Modeling Solution in Disease Modeling
Figure 15. Global New Drug Modeling Solution Market: Disease Modeling (2021-2026) & ($ millions)
Figure 16. New Drug Modeling Solution in Others
Figure 17. Global New Drug Modeling Solution Market: Others (2021-2026) & ($ millions)
Figure 18. Global New Drug Modeling Solution Market Size Market Share by Application in 2025
Figure 19. Global New Drug Modeling Solution Revenue Market Share by Player in 2025
Figure 20. Global New Drug Modeling Solution Market Size Market Share by Region (2021-2026)
Figure 21. Americas New Drug Modeling Solution Market Size 2021-2026 ($ millions)
Figure 22. APAC New Drug Modeling Solution Market Size 2021-2026 ($ millions)
Figure 23. Europe New Drug Modeling Solution Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa New Drug Modeling Solution Market Size 2021-2026 ($ millions)
Figure 25. Americas New Drug Modeling Solution Value Market Share by Country in 2025
Figure 26. United States New Drug Modeling Solution Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada New Drug Modeling Solution Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico New Drug Modeling Solution Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil New Drug Modeling Solution Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC New Drug Modeling Solution Market Size Market Share by Region in 2025
Figure 31. APAC New Drug Modeling Solution Market Size Market Share by Type (2021-2026)
Figure 32. APAC New Drug Modeling Solution Market Size Market Share by Application (2021-2026)
Figure 33. China New Drug Modeling Solution Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan New Drug Modeling Solution Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea New Drug Modeling Solution Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia New Drug Modeling Solution Market Size Growth 2021-2026 ($ millions)
Figure 37. India New Drug Modeling Solution Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia New Drug Modeling Solution Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe New Drug Modeling Solution Market Size Market Share by Country in 2025
Figure 40. Europe New Drug Modeling Solution Market Size Market Share by Type (2021-2026)
Figure 41. Europe New Drug Modeling Solution Market Size Market Share by Application (2021-2026)
Figure 42. Germany New Drug Modeling Solution Market Size Growth 2021-2026 ($ millions)
Figure 43. France New Drug Modeling Solution Market Size Growth 2021-2026 ($ millions)
Figure 44. UK New Drug Modeling Solution Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy New Drug Modeling Solution Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia New Drug Modeling Solution Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa New Drug Modeling Solution Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa New Drug Modeling Solution Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa New Drug Modeling Solution Market Size Market Share by Application (2021-2026)
Figure 50. Egypt New Drug Modeling Solution Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa New Drug Modeling Solution Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel New Drug Modeling Solution Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey New Drug Modeling Solution Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries New Drug Modeling Solution Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas New Drug Modeling Solution Market Size 2027-2032 ($ millions)
Figure 56. APAC New Drug Modeling Solution Market Size 2027-2032 ($ millions)
Figure 57. Europe New Drug Modeling Solution Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa New Drug Modeling Solution Market Size 2027-2032 ($ millions)
Figure 59. United States New Drug Modeling Solution Market Size 2027-2032 ($ millions)
Figure 60. Canada New Drug Modeling Solution Market Size 2027-2032 ($ millions)
Figure 61. Mexico New Drug Modeling Solution Market Size 2027-2032 ($ millions)
Figure 62. Brazil New Drug Modeling Solution Market Size 2027-2032 ($ millions)
Figure 63. China New Drug Modeling Solution Market Size 2027-2032 ($ millions)
Figure 64. Japan New Drug Modeling Solution Market Size 2027-2032 ($ millions)
Figure 65. Korea New Drug Modeling Solution Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia New Drug Modeling Solution Market Size 2027-2032 ($ millions)
Figure 67. India New Drug Modeling Solution Market Size 2027-2032 ($ millions)
Figure 68. Australia New Drug Modeling Solution Market Size 2027-2032 ($ millions)
Figure 69. Germany New Drug Modeling Solution Market Size 2027-2032 ($ millions)
Figure 70. France New Drug Modeling Solution Market Size 2027-2032 ($ millions)
Figure 71. UK New Drug Modeling Solution Market Size 2027-2032 ($ millions)
Figure 72. Italy New Drug Modeling Solution Market Size 2027-2032 ($ millions)
Figure 73. Russia New Drug Modeling Solution Market Size 2027-2032 ($ millions)
Figure 74. Egypt New Drug Modeling Solution Market Size 2027-2032 ($ millions)
Figure 75. South Africa New Drug Modeling Solution Market Size 2027-2032 ($ millions)
Figure 76. Israel New Drug Modeling Solution Market Size 2027-2032 ($ millions)
Figure 77. Turkey New Drug Modeling Solution Market Size 2027-2032 ($ millions)
Figure 78. Global New Drug Modeling Solution Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global New Drug Modeling Solution Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries New Drug Modeling Solution Market Size 2027-2032 ($ millions)
Figure 1. New Drug Modeling Solution Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global New Drug Modeling Solution Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. New Drug Modeling Solution Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. New Drug Modeling Solution Sales Market Share by Country/Region (2025)
Figure 8. New Drug Modeling Solution Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global New Drug Modeling Solution Market Size Market Share by Type in 2025
Figure 10. New Drug Modeling Solution in Drug Discovery and Development
Figure 11. Global New Drug Modeling Solution Market: Drug Discovery and Development (2021-2026) & ($ millions)
Figure 12. New Drug Modeling Solution in Computational Physiological Medicine
Figure 13. Global New Drug Modeling Solution Market: Computational Physiological Medicine (2021-2026) & ($ millions)
Figure 14. New Drug Modeling Solution in Disease Modeling
Figure 15. Global New Drug Modeling Solution Market: Disease Modeling (2021-2026) & ($ millions)
Figure 16. New Drug Modeling Solution in Others
Figure 17. Global New Drug Modeling Solution Market: Others (2021-2026) & ($ millions)
Figure 18. Global New Drug Modeling Solution Market Size Market Share by Application in 2025
Figure 19. Global New Drug Modeling Solution Revenue Market Share by Player in 2025
Figure 20. Global New Drug Modeling Solution Market Size Market Share by Region (2021-2026)
Figure 21. Americas New Drug Modeling Solution Market Size 2021-2026 ($ millions)
Figure 22. APAC New Drug Modeling Solution Market Size 2021-2026 ($ millions)
Figure 23. Europe New Drug Modeling Solution Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa New Drug Modeling Solution Market Size 2021-2026 ($ millions)
Figure 25. Americas New Drug Modeling Solution Value Market Share by Country in 2025
Figure 26. United States New Drug Modeling Solution Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada New Drug Modeling Solution Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico New Drug Modeling Solution Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil New Drug Modeling Solution Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC New Drug Modeling Solution Market Size Market Share by Region in 2025
Figure 31. APAC New Drug Modeling Solution Market Size Market Share by Type (2021-2026)
Figure 32. APAC New Drug Modeling Solution Market Size Market Share by Application (2021-2026)
Figure 33. China New Drug Modeling Solution Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan New Drug Modeling Solution Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea New Drug Modeling Solution Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia New Drug Modeling Solution Market Size Growth 2021-2026 ($ millions)
Figure 37. India New Drug Modeling Solution Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia New Drug Modeling Solution Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe New Drug Modeling Solution Market Size Market Share by Country in 2025
Figure 40. Europe New Drug Modeling Solution Market Size Market Share by Type (2021-2026)
Figure 41. Europe New Drug Modeling Solution Market Size Market Share by Application (2021-2026)
Figure 42. Germany New Drug Modeling Solution Market Size Growth 2021-2026 ($ millions)
Figure 43. France New Drug Modeling Solution Market Size Growth 2021-2026 ($ millions)
Figure 44. UK New Drug Modeling Solution Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy New Drug Modeling Solution Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia New Drug Modeling Solution Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa New Drug Modeling Solution Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa New Drug Modeling Solution Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa New Drug Modeling Solution Market Size Market Share by Application (2021-2026)
Figure 50. Egypt New Drug Modeling Solution Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa New Drug Modeling Solution Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel New Drug Modeling Solution Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey New Drug Modeling Solution Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries New Drug Modeling Solution Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas New Drug Modeling Solution Market Size 2027-2032 ($ millions)
Figure 56. APAC New Drug Modeling Solution Market Size 2027-2032 ($ millions)
Figure 57. Europe New Drug Modeling Solution Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa New Drug Modeling Solution Market Size 2027-2032 ($ millions)
Figure 59. United States New Drug Modeling Solution Market Size 2027-2032 ($ millions)
Figure 60. Canada New Drug Modeling Solution Market Size 2027-2032 ($ millions)
Figure 61. Mexico New Drug Modeling Solution Market Size 2027-2032 ($ millions)
Figure 62. Brazil New Drug Modeling Solution Market Size 2027-2032 ($ millions)
Figure 63. China New Drug Modeling Solution Market Size 2027-2032 ($ millions)
Figure 64. Japan New Drug Modeling Solution Market Size 2027-2032 ($ millions)
Figure 65. Korea New Drug Modeling Solution Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia New Drug Modeling Solution Market Size 2027-2032 ($ millions)
Figure 67. India New Drug Modeling Solution Market Size 2027-2032 ($ millions)
Figure 68. Australia New Drug Modeling Solution Market Size 2027-2032 ($ millions)
Figure 69. Germany New Drug Modeling Solution Market Size 2027-2032 ($ millions)
Figure 70. France New Drug Modeling Solution Market Size 2027-2032 ($ millions)
Figure 71. UK New Drug Modeling Solution Market Size 2027-2032 ($ millions)
Figure 72. Italy New Drug Modeling Solution Market Size 2027-2032 ($ millions)
Figure 73. Russia New Drug Modeling Solution Market Size 2027-2032 ($ millions)
Figure 74. Egypt New Drug Modeling Solution Market Size 2027-2032 ($ millions)
Figure 75. South Africa New Drug Modeling Solution Market Size 2027-2032 ($ millions)
Figure 76. Israel New Drug Modeling Solution Market Size 2027-2032 ($ millions)
Figure 77. Turkey New Drug Modeling Solution Market Size 2027-2032 ($ millions)
Figure 78. Global New Drug Modeling Solution Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global New Drug Modeling Solution Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries New Drug Modeling Solution Market Size 2027-2032 ($ millions)
